SVRA

Savara, Inc.

3.78 USD
+0.06 (+1.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Savara, Inc. stock is down -12.7% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 11 June’s closed higher than May.

About Savara, Inc.

Savara Inc. focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor. The company is headquartered in Austin, Texas.